WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997035879) MYELIN OLIGODENDROCYTE GLYCOPROTEIN PEPTIDES AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/035879    International Application No.:    PCT/US1996/006072
Publication Date: 02.10.1997 International Filing Date: 01.05.1996
Chapter 2 Demand Filed:    09.10.1997    
IPC:
A61K 39/00 (2006.01), C07K 14/47 (2006.01)
Applicants: IMMULOGIC PHARMACEUTICAL CORPORATION [US/US]; 610 Lincoln Street, Waltham, MA 02154 (US)
Inventors: DEVAUX, Brigitte; (US).
ROTHBARD, Jonathan; (US).
SMILEK, Dawn; (US).
WALLNER, Barbara; (US).
GARMAN, Richard, D.; (US)
Agent: MANDRAGOURAS, Amy, E.; Lahive & Cockfiel, LLP, 28 State Street, Boston, MA 02109 (US)
Priority Data:
08/623,406 28.03.1996 US
Title (EN) MYELIN OLIGODENDROCYTE GLYCOPROTEIN PEPTIDES AND USES THEREOF
(FR) PEPTIDES DE LA GLYCOPROTEINE D'OLIGODENDROCYTE DE MYELINE ET LEURS UTILISATIONS
Abstract: front page image
(EN)The present invention provides peptides of human myelin oligodendrocyte glycopeptide (MOG), an autoantigen related to demyelinating autoimmune diseases. The present invention also provides compositions including MOG peptides or mixtures of MOG peptides and myelin basic peptide (MBP) peptides. Also provided are therapeutic compositions useful for diagnosing and treating autoimmune diseases, and methods of treating multiple sclerosis using such therapeutic compositions.
(FR)La présente invention concerne des peptides de la glycoprotéine d'oligodendrocyte de myéline humaine (MOG), auto-antigène lié aux maladies auto-immunes démyélinissantes. La présente invention concerne également certaines compositions incluant des peptides MOG ou des mélanges de peptides MOG et de peptides du peptide MBP. Enfin, la présente invention concerne aussi certaines compositions thérapeutiques servant au diagnostic et au traitement de certaines maladies auto-immunes ainsi que des méthodes de traitement de la sclérose en plaques au moyen desdites compositions thérapeutiques.
Designated States: AL, AM, AT, AU, AZ, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, EE, FI, GB, GE, HU, IS, JP, KE, KG, KP, KR, KZ, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, UZ, VN.
African Regional Intellectual Property Organization (KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)